1. Allergan is Buying a Biotech Company for $2.1 billion (AGN, Kyth, Ibb)

    Allergan is Buying a Biotech Company for $2.1 billion (AGN, Kyth, Ibb)

    In a statement on Wednesday, the companies announced that Allergan will pay $75 per Kythera share; 80% will be in cash, and the remaining 20% in new Allergen shares for Kythera shareholders. Allergan is a pharmaceutical company and the maker of Botox. By acquiring Kythera, Allergan adds an injection that treats double chin to its portfolio, called Kybella, the companies noted...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned

  3. Authors